Follow The Filings

FTLF FitLife Brands

FitLife Brands earnings company data as of 4:48 AM ET 10/23

  • 1 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS 0.25 — —
Rev — — —
FY2026 Q2 13 Aug EPS 0.18 0.20 Beat +11.1%
Rev — $26.5M —

Insider trades

Open-market buys and sales by FTLF's executives, directors and 10% owners in the last 12 months, from their Form 4s

All FTLF insider trades
  • $72K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Shannon K. Pappas Director
    Buy
    $10K 1,000 shares at $10.25 New stake
    Traded Aug 19 Filed Aug 21
    ↗
  2. Seth Yakatan Director
    Buy
    $2,519 164 shares at $15.36 +38% to stake
    Traded Jan 15 Filed Apr 20
    ↗
  3. Matthew Lingenbrink Director
    Buy
    $29K 3,000 shares at $9.76 +52% to stake
    Traded Apr 10 Filed Apr 14
    ↗
  4. Grant Robert Dawson Director
    Buy
    $30K 3,000 shares at $9.98 +1.9% to stake
    Traded Apr 10 Filed Apr 14
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 2.02,5.07,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A FORM DEF 14A Filing Doc
DEFA14A FORM DEFA14A Filing Doc
DEFA14A FORM DEFA14A Filing Doc
8-K 5.02 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K/A FORM 10-K/A Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K FORM 10-K Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K/A 9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 1.01,2.01,2.03,8.01,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
DEF 14A FORM DEF 14A Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.